All In MedTech

510(k) device

EchoTip AcuCore EUS Biopsy Needle (ECHO-BX-19)

Cook Ireland, Ltd. · Biopsy Needle (FCG, Class II) · First FDA decision Jul 29, 2024, newest Jul 29, 2024Cancer detection and genomic testing

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

510(k) pathway

Device trials

1

Naming "EchoTip AcuCore EUS"

MAUDE reports

4

Brand "EchoTip AcuCore EUS", since 2015

PubMed studies

0

Mentioning "EchoTip AcuCore EUS"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing EchoTip AcuCore EUS Biopsy Needle (ECHO-BX-19)

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "EchoTip AcuCore EUS", any status and sponsor, newest update first.

Open in Trial Radar
  • Cook Research IncorporatedNot on our public-company list

    NCT06358001 · 183 participants · Start Aug 5, 2024 · Primary completion Jun 14, 2025

    Device: EchoTip AcuCore · For: Adenocarcinoma; Neuroendocrine Tumors; Hepatocellular Carcinoma and 5 more

    Sites: Orange, California; Denver, Colorado; Gainesville, Florida · 8 sites in all

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "EchoTip AcuCore EUS", and for the whole product code for context.

This brand

4 reports: 3 malfunction, 1 injury, 0 death

Whole product code FCG

4,062 reports: 3,169 malfunction, 865 injury, 22 death

Newest reports for this brand

1 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recall in FDA's data is linked to these FDA numbers.

Published research

The most relevant PubMed records for "EchoTip AcuCore EUS"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

No PubMed record mentions this device by name.

Other devices of this type

Also filed under product code FCG.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.